Pretreatment by hyperoxia - A tool to reduce ischaemia-reperfusion injury in the myocardium

Current Clinical Pharmacology

Volumn 5, Issue 2, 2010, Pages 125-132

  Karu, Inga ^a,b   Tähepõld, Peeter ^b,c   Ruusalepp, Arno ^b,c   Starkopf, Joel ^b,c  

^a North Estonia Medical Centre   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

Hyperbaric oxygenation; Hyperoxia; Ischaemia reperfusion injury; Myocardium; Oxidative stress; Preconditioning; Reactive oxygen species

Indexed keywords

OXYGEN; REACTIVE OXYGEN METABOLITE;

AEROBIC METABOLISM; ATHEROSCLEROSIS; BLOOD CLOT LYSIS; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; HYPERBARIC OXYGEN; HYPEROXIA; ISCHEMIC PRECONDITIONING; NONHUMAN; OXIDATIVE STRESS; OXYGEN SUPPLY; OXYGEN TENSION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPERFUSION INJURY; REVASCULARIZATION; REVIEW;

ANIMALS; ATHEROSCLEROSIS; HUMANS; HYPEROXIA; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS;

EID: 77951524034     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488410791110788     Document Type: Review

References (128)

1. Jennings RB, Sommers HM, Smyth GA, Flack HA, Linn H. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol 1960; 70: 68-78.
2. Bulkley BH, Hutchins GM. Myocardial consequences of coronary artery bypass graft surgery. The paradox of necrosis in areas of revascularization. Circulation 1977; 56: 906-913
3. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest 1985; 76: 1713-9.
4. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon following temporary coronary occlusion in the dog. J Clin Invest 1974; 54: 1496-1508
5. Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. Myocardial ischemia/reperfusion injury: a clinical view on a complex pathophysiological process. Int J Cardiol 2005; 100: 179-190
6. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007; 357: 1121-1135
7. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996; 79: 949-956
8. Gottlieb RA, Burleson KO, Kloner RA, Babior, BM, Engler, RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94: 1621-1628
9. Foo R, Mani K, Kitsis RN. Death begets failure in the heart. J Clin Invest 2005; 115: 565-571
10. Gustafsson A, Gottlieb RA. Recycle or die: The role of autophagy in cardioprotection. J Mol Cell Cardiol 2008; 44: 654-661
11. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136
12. Das M, Das DK. Molecular mechanism of preconditioning. IUBMB Life 2008; 60: 199-203.
13. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993; 342: 276-277
14. Illes RW, Swoyer KD. Prospective, randomized clinical study of ischemic preconditioning as an adjunct to intermittent cold blood cardioplegia. Ann Thorac Surg 1998; 65: 748-752
15. Lu EX, Chen SX, Hu TH, Xui LM, Yuan MD. Preconditioning enhances myocardial protection in patients undergoing open heart surgery. Thorac Cardiovasc Surg 1998; 46: 28-32.
16. Wu ZK, Tarkka MR, Pehkonen E, Kaukinen L, Honkonen EL, Kaukinen S. Beneficial effects of ischemic preconditioning on right ventricular function after coronary artery bypass grafting. Ann Thorac Surg 2000; 70: 1551-1557
17. Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997; 77: 314-318
18. Szmagala P, Morawski W, Krejca M, Gburek T, Bochenek A. Evaluation of perioperative myocardial tissue damage in ischemically preconditioned human heart during aorto coronary bypass surgery. J Cardiovasc Surg (Torino) 1998; 39: 791-795
19. Wei M, Kuukasjarvi P, Laurikka J et al. Cytokine responses in patients undergoing coronary artery bypass surgery after ischemic preconditioning. Scand Cardiovasc J 2001; 35: 142-146 (Pubitemid 32451659)
20. Wu ZK, Iivainen T, Pehkonen E, Laurikka J, Tarkka MR. Ischemic preconditioning suppresses ventricular tachyarrhythmias after myocardial revascularization. Circulation 2002; 106: 3091-3096
21. Kharbanda RK, Peters M, Walton B et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 2001; 103: 1624-1630
22. Vaage J, Jensen U, Ericsson A. Neurologic injury in cardiac surgery: aortic atherosclerosis emerges as the single most important risk factor. Scand Cardiovasc J 2000; 34: 550-557
23. Landoni G, Biondi-Zoccai GG, Zangrillo A et al. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007; 21: 502-511 (Pubitemid 47135634)
24. Bell SP, Sack MN, Patel A, Opie LH, Yellon DM. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol 2000; 36: 2296-2302
25. Murphy GS, Szokol JW, Marymont JH, Avram MJ, Vender JS. Opioids and cardioprotection: the impact of morphine and fentanyl on recovery of ventricular function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2006; 20: 493-502.
26. Lai CC, Peng M, Huang L, Huang WH, Chiu TH. Chronic exposure of neonatal cardiac myocytes to hydrogen peroxide enhances the expression of catalase. J Mol Cell Cardiol 1996; 28: 1157-1163
27. Zhou X, Zhai X, Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation 1996; 93: 1177-1184
28. Lee ES, Smith WE, Quach HT, Jones BD, Santilli SM, Vatassery GT. Moderate hyperoxia (40%) increases antioxidant levels in mouse tissue. J Surg Res 2005; 127: 80-84
29. Brown JM, White CW, Terada LS et al. Interleukin 1 pretreatment decreases ischemia/reperfusion injury. Proc Natl Acad Sci 1990; 87: 5026-5030
30. Currie RW, Tanguay RM. Analysis of RNA for transcripts for catalase and HSP71 in rat hearts after in vivo hyperthermia. Biochem Cell Biol 1991; 69: 375-382
31. Hoshida S, Kuzuya T, Yamashita N et al. Brief myocardial ischemia affects free radical generating and scavenging systems in dogs. Heart Vessels 1993; 8: 115-120
32. Murry CE, Richard VJ, Jennings RB, Reimer KA. Preconditioning with ischemia: is the protective effect mediated by free radical induced myocardial stunning? Circulation 1988; 78 (Suppl II): 77 (Abstract).
33. Tritto I, D'Andrea D, Eramo N et al. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 1997; 80: 743-748
34. Valen G, Starkopf J, Takeshima S et al. Preconditioning with hydrogen peroxide (H2O2) or ischemia in H2O2-induced cardiac dysfunction. Free Radic Res 1998; 29: 235-245
35. Kabir AM, Clark JE, Tanno M et al. Cardioprotection initiated by reactive oxygen species is dependent on activation of PKCepsilon. Am J Physiol Heart Circ Physiol 2006; 291: H1893-9.
36. Hoshida S, Kuzuya T, Fuji H et al. Sublethal ischemia alters myocardial antioxidant activity in canine heart. Am J Physiol 1993; 264: H33-9.
37. Zhai X, Zhou X, Ashraf M. Late ischemic preconditioning is mediated in myocytes by enhanced endogenous antioxidant activity stimulated by oxygen-derived free radicals. Ann N Y Acad Sci 1996; 793: 156-166
38. Khanna G, Diwan V, Singh M, Jaggi AS. Reduction of ischemic, pharmacological and remote preconditioning effects by an antioxidant N-acetyl cysteine pretreatment in isolated rat heart. Yakugaku Zasshi 2008; 128: 469-477
39. Osada M, Takeda S, Sato T, Komori S, Tamura K. The protective effect of preconditioning on reperfusion-induced arrhythmias is lost by treatment with superoxide dismutase. Jpn Circ J 1994; 58: 259-263
40. Kals J, Starkopf J, Zilmer M et al. Antioxidant UPF1 attenuates myocardial stunning in isolated rat hearts. Int J Cardiol 2008; 125: 133-135
41. Tritto I, D'Andrea D, Eramo N et al. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 1997; 80: 743-748
42. Ytrehus K, Walsh RS, Richards SC, Downey JM. Hydrogen peroxide as a protective agent during reperfusion. A study in the isolated perfused rabbit heart subjected to regional ischemia. Cardiovasc Res 1995; 30: 1033-1037
43. Hegstad AC, Antonsen OH, Ytrehus K. Low concentrations of hydrogen peroxide improve post-ischemic metabolic and functional recovery in isolated perfused rat heart. J Mol Cell Cardiol 1997; 29: 2779-2787
44. Tähepõld P, Valen G, Starkopf J, Kairane C, Zilmer M, Vaage J. Pretreating rats with hyperoxia attenuates ischemia-reperfusion injury of the heart. Life Sci 2001; 68: 1629-1640
45. Choi H, Kim SH, Chun YS, Cho YS, Park JW, Kim MS. In vivo hyperoxic preconditioning prevents myocardial infarction by expressing bcl-2. Exp Biol Med (Maywood) 2006; 231: 463-472
46. Colantuono G, Tiravanti EA, Di Venosa N et al. Hyperoxia confers myocardial protection in mechanically ventilated rats through the generation of free radicals and opening of mitochondrial ATP-sensitive potassium channels. Clin Exp Pharmacol Physiol 2008; 35: 64-71.
47. Mover-Lev H, Ar A. Changes in enzymatic antioxidant activity in pregnant rats exposed to hyperoxia or hypoxia. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1997; 118: 353-359 (Pubitemid 28053623)
48. Lee ES, Smith WE, Quach HT, Jones BD, Santilli SM, Vatassery GT. Moderate hyperoxia (40%) increases antioxidant levels in mouse tissue. J Surg Res 2005; 127: 80-84
49. Stock MK, Silvernail KK, Metcalfe J. Prenatal oxidative stress: I. Malondialdehyde in hypoxic and hyperoxic chick embryos. Free Radic Biol Med 1990; 8: 313-318
50. Bigdeli MR, Rasoulian B, Meratan AA. In vivo normobaric hyperoxic preconditioning induces different degrees of antioxidant enzymes activities in rat brain tissue. Eur J Pharmacol 2009; 611: 22-29
51. Ahotupa M, Mäntylä E, Peltola V, Puntala A, Toivonen H. Prooxidant effects of normobaric hyperoxia in rat tissues. Acta Physiol Scand 1992; 145: 151-157
52. Gille JJ, Joenje H. Cell culture models for oxidative stress: superoxide and hydrogen peroxide versus normobaric hyperoxia. Mutat Res 1992; 275: 405-414
53. Van Klaveren RJ, Roelant C, Boogaerts M, Pype JL, Demedts M, Nemery B. Protective effects of the lazaroid U-74389G against hyperoxia in rat type II pneumocytes. Pulm Pharmacol Ther 1998; 11: 23-30.
54. Honda S, Hjelmeland LM, Handa JT. The use of hyperoxia to induce chronic mild oxidative stress in RPE cells in vitro. Mol Vis 2001; 7: 63-70.
55. Li G, Tokuno S, Tähepõld P, Vaage J, Löwbeer C, Valen G. Preconditioning protects the severely atherosclerotic mouse heart. Ann Thorac Surg 2001; 71: 1296-1304.
56. Tähepõld P, Ruusalepp A, Li G, Vaage J, Starkopf J, Valen G. Cardioprotection by breathing hyperoxic gas - relation to oxygen concentration and exposure time in rats and mice. Eur J Cardiothorac 2002; 21:987-994
57. Tähepõld P, Elfström P, Eha I et al. Exposure of rats to hyperoxia enhances relaxation of isolated aortic rings and reduces infarct size of isolated hearts. Acta Physiol Scand 2002; 175: 271-277
58. Tähepõld P, Vaage J, Starkopf J, Valen G. Hyperoxia elicits myocardial protection through a NFêB-dependent mechanism in the rat heart. J Thorac Cardiovasc Surg 2003; 125: 650-660
59. Esmaili Dehaj M, Baharvand B, Rasoulian B et al. Delayed protective effects of hyperoxia against cardiac arrhythmias and infarction in anesthetized rats. J Surg Res 2009; 151: 55-61.
60. Kaljusto ML, Stenslokken KO, Mori T et al. Preconditioning effects of steroids and hyperoxia on cardiac ischemia-reperfusion injury and vascular reactivity. Eur J Cardiothorac Surg 2008; 33: 355-363
61. Pourkhalili K, Hajizadeh S, Tiraihi T et al. Ischemia and reperfusion-induced arrhythmias: role of hyperoxic preconditioning. J Cardiovasc Med (Hagerstown) 2009; 10: 635-642
62. Baharvand B, Dehaj ME, Foadaddini M et al. Delayed Cardioprotective Effects of Hyperoxia Preconditioning Prolonged by Intermittent Exposure. J Surg Res 2009 Jan 24. [Epub ahead of print].
63. Labruto F, Yang J, Vaage J, Valen G. Role of tumor necrosis factor alpha and its receptor I in preconditioning by hyperoxia. Basic Res Cardiol 2005; 100: 198-207.
64. Ruusalepp A, Czibik G, Flatebo T, Vaage J, Valen G. Myocardial protection evoked by hyperoxic exposure involves signalling through nitric oxide and mitogen activated protein kinases. Basic Res Cardiol 2007; 102: 318-326
65. Juhaszova M, Wang S, Zorov DB et al. The identity and regulation of the mitochondrial permeability transition pore: where the known meets the unknown. Ann N Y Acad Sci 2008; 1123: 197-212.
66. Ferrari R, Alfieri O, Curello S et al. Occurrence of oxidative stress during reperfusion of the human heart. Circulation 1990; 81: 201-211
67. De Vecchi E, Pala MG, Di Credico G et al. Relation between left ventricular function and oxidative stress in patients undergoing bypass surgery. Heart 1998; 79: 242-247
68. Volk T, Schmutzler M, Engelhardt L et al. Effects of different steroid treatment on reperfusion-associated production of reactive oxygen species and arrhythmias during coronary surgery. Acta Anaesthesiol Scand 2003; 47: 667-674
69. Karu I, Loit R, Zilmer K et al. Pre-treatment with hyperoxia before coronary artery bypass grafting - effects upon myocardial injury and inflammatory response. Acta Anaesthesiol Scand 2007; 51: 1305-1313
70. Karu I, Loit R, Paapstel A, Kairane C, Zilmer M, Starkopf J. Early postoperative function of the heart after coronary artery bypass grafting is not predicted by myocardial necrosis and glutathione-associated oxidative stress. Clin Chim Acta 2005; 359: 195-202.
71. Wu ZK, Tarkka MR, Eloranta J et al. Effect of ischemic preconditioning on myocardial protection in coronary artery bypass graft patients: can the free radicals act as a trigger for ischemic preconditioning? Chest 2001; 119: 1061-1068
72. Hennein HA, Ebba H, Rodriguez JL et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994; 108: 626-635
73. Ikonomidis I, Athanassopoulos G, Lekakis J et al. Myocardial ischemia induces interleukin-6 and tissue factor production in patients with coronary artery disease: a dobutamine stress echocardiography study. Circulation 2005; 112: 3272-3279
74. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric-oxide. Science 1992; 257: 387-389
75. Mitchell JD, Grocott HP, Phillips-Bute B, Mathew JP, Newman MF, Bar-Yosef S. Cytokine secretion after cardiac surgery and its relationship to postoperative fever. Cytokine 2007; 38:37-42.
76. Bennermo M, Held C, Green F et al. Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis 2004; 174: 157-163
77. Lehmann LE, Schroeder S, Hartmann W et al. A single nucleotide polymorphism of macrophage migration inhibitory factor is related to inflammatory response in coronary bypass surgery using cardiopulmonary bypass. Eur J Cardiothorac Surg 2006; 30: 59-63.
78. Christen S, Finckh B, Lykkesfeldt J et al. Oxidative stress precedes peak systemic inflammatory response in pediatric patients undergoing cardiopulmonary bypass operation. Free Radic Biol Med 2005; 38: 1323-1332
79. Wilson EM, Diwan A, Spinale FG, Mann DL. Duality of innate stress responses in cardiac injury, repair, and remodeling. J Mol Cell Cardiol 2004; 37: 801-811
80. Wan S, Barvais L, Goldstein M, Vincent JL, LeClerc JL. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 112: 806-811
81. Koskenkari JK, Kaukoranta PK, Rimpilainen J et al. Antiinflammatory effect of high-dose insulin treatment after urgent coronary revascularization surgery. Acta Anaesthesiol Scand 2006; 50: 962-969
82. Kaneda T, Ku K, Inoue T, Onoe M, Oku H. Postischemic reperfusion injury can be attenuated by oxygen tension control. Jpn Circ J 2001; 65: 213-218
83. Li G, Chen S, Lu E, Li Y . Ischemic preconditioning improves preservation with cold blood cardioplegia in valve replacement patients. Eur J Cardiothorac Surg 1999; 15: 653-657
84. Cremer J, Steinhoff G, Karck M et al. Ischemic preconditioning prior to myocardial protection with cold blood cardioplegia in coronary surgery. Eur J Cardiothorac Surg 1997; 12: 753-758
85. Kaukoranta PK, Lepojarvi MPK, Ylitalo KV et al. Normothermic retrograde blood cardioplegia with or without preceding ischemic preconditioning. Ann Thorac Surg 1997; 63: 1268-1274
86. Perrault LP, Menasche P. Preconditioning: can nature's shield be raised against surgical ischemic-reperfusion injury? Ann Thorac Surg 1999; 68: 1988-1994
87. Sterling DL, Thornton JD, Swafford A, et al. Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation 1993; 88: 1931-1936
88. Yogaratnam JZ, Laden G, Guvendik L, Cowen M, Cale A, Griffin S. Pharmacological preconditioning with hyperbaric oxygen: can this therapy attenuate myocardial ischemic reperfusion injury and induce myocardial protection via nitric oxide? J Surg Res 2008; 149: 155-164
89. Cabigas BP, Su J, Hutchins W et al. Hyperoxic and hyperbaricinduced cardioprotection: Role of nitric oxide synthase 3. Cardiovasc Res 2006; 72: 143-151
90. Kim CH, Choi H, Chun YS, Kim GT, Park JW, Kim MS. Hyperbaric oxygenation pretreatment induces catalase and reduces infarct size in ischemic rat myocardium. Pflugers Arch 2001; 442: 519-525
91. Xuejun S, Han C, Lin L et al. Hyperbaric oxygen preconditioning alleviates myocardial ischemic injury in rats. Exp Biol Med (Maywood) 2008; 233:1448-1453
92. Aparci M, Kardesoglu E, Suleymanoglu S, Uzun G. Hyperbaric oxygen therapy improves myocardial diastolic function in diabetic patients. Tohoku J Exp Med 2008; 214: 281-289 (Pubitemid 351513539)
93. Shandling AH, Ellestad MH, Hart GB et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the "HOT MI" pilot study. Am Heart J 1997; 134: 544-550
94. Dekleva M, Neskovic A, Vlahovic A, Putnikovic B, Beleslin B, Ostojic M. Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. Am Heart J 2004; 148: E14.
95. Stogner SW and Payne DK. Oxygen toxicity. Ann Pharmacother 1992; 26: 1554-1562
96. Rockswold SB, Rockswold GL, Zaun DA et al. A prospective, randomized clinical trial to compare the effect of hyperbaric to normobaric hyperoxia on cerebral metabolism, intracranial pressure, and oxygen toxicity in severe traumatic brain injury. Neurosurg 2009 Oct 23. [Epub ahead of print],
97. Hendricks PL, Hall DA, Hunter WL Jr, Haley PR. Extension of pulmonary O2 tolerance in man at 2 ATA by intermittent O2 exposure. J Appl Physiol 1997; 42: 593-599
98. Carvalho CR, de Paula Pinto Schettino G, Maranhao B, Bethlem EP. Hyperoxia and lung disease. Curr Opin Pulm Med 1998; 4: 300-304
99. Sinclair SE, Altemeier WA, Matute-Bello G, Chi EY. Augmented lung injury due to interaction between hyperoxia and mechanical ventilation. Crit Care Med 2004; 32: 2496-2501
100. Li LF, Liao SK, Ko YS, Lee CH, Quinn DA. Hyperoxia increases ventilator-induced lung injury via mitogen activated protein kinases - a prospective, controlled animal experiment. Crit Care 2007; 11: R25.
101. Rothen HU, Sporre B, Engberg G, Wegenius G, Hogman M, Hedenstierna G. Influence of gas composition on recurrence of atelectasis after a reexpansion maneuver during general anesthesia. Anesthesiology 1995; 82: 832-842
102. Benoit Z, Wicky S, Fischer JF, et al. The effect of increased FIO(2) before tracheal extubation on postoperative atelectasis. Anesth Analg 2002; 95: 1777-1781
103. Akca O, Podolsky A, Eisenhuber E et al. Comparable postoperative pulmonary atelectasis in patients given 30% or 80% oxygen during and 2 hours after colon resection. Anesthesiology 1999; 91: 991-998
104. Greif R, Akca O, Horn EP, Kurz A, Sessler DI. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med 2000; 342: 161-167 (Pubitemid 30051647)
105. Akca O, Melischek M, Scheck T et al. Postoperative pain and subcutaneous oxygen tension. Lancet 1999; 354: 41-42
106. Brar MS, Brar SS, Dixon E. Perioperative supplemental oxygen in colorectal patients: A meta-analysis. J Surg Res 2009 Jul 10. [Epub ahead of print]
107. Al-Niaimi A, Safdar N. Supplemental perioperative oxygen for reducing surgical site infection: a meta-analysis.. J Eval Clin Pract 2009; 15: 360-365
108. Kotani N, Hashimoto H, Sessler DI et al. Supplemental intraoperative oxygen augments antimicrobial and proinflammatory responses of alveolar macrophages. Anesthesiology 2000; 93: 15-25.
109. Greif R, Laciny S, Rapf B, Hickle RS, Sessler DI. Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology 1999; 91: 1246-1252
110. Goll V, Akca O, Greif R et al. Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting. Anesth Analg 2001; 92: 112-117
111. Turan A, Apfel CC, Kumpch M et al. Does the efficacy of supplemental oxygen for the prevention of postoperative nausea and vomiting depend on the measured outcome, observational period or site of surgery? Anaesthesia 2006; 61: 628-633
112. Treschan TA, Zimmer C, Nass C, Stegen B, Esser J, Peters J. Inspired oxygen fraction of 0.8 does not attenuate postoperative nausea and vomiting after strabismus surgery. Anesthesiology 2005; 103: 6-10.
113. Kim HY, Singhal AB, Lo EH. Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann Neurol 2005; 57: 571-575
114. Singhal AB, Benner T, Roccatagliata L et al. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 2005; 36: 797-802.
115. Corradini SG, Elisei W, De Marco R et al. Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation. Liver Transpl 2005; 11: 140-151
116. Rasoulian B, Mohammadhosseniakbari H. Preconditioning with oxygen attenuates rat renal ischemia-reperfusion injury. J Surg Res 2008; 146:282-288
117. Wahhabaghai H, Rasoulian B, Esmaili M et al. Hyperoxia-induced protection against rat's renal ischemic damage: relation to oxygen exposure time. Ren Fail 2009; 31: 514-521
118. Hou L, Xie K, Qin M et al. Effects of Reactive Oxygen Species (ROS) scavenger on the protective action of 100% oxygen treatment against sterile inflammation in mice. Shock 2009 Sep 25. [Epub ahead of print].
119. Barth E, Bassi G, Maybauer DM et al. Effects of ventilation with 100% oxygen during early hyperdynamic porcine fecal peritonitis. Crit Care Med 2008; 36: 495-503.
120. Kumaria A, Tolias CM. Normobaric hyperoxia therapy for traumatic brain injury and stroke: a review. Br J Neurosurg 2009; 23: 576-584
121. Frobert O, Moesgaard J, Toft E, Poulsen SH, Sogaard P. Influence of oxygen tension on myocardial performance. Evaluation by tissue Doppler imaging. Cardiovasc Ultrasound 2004; 2: 22.
122. Anderson KJ, Harten JM, Booth MG, Kinsella J. The cardiovascular effects of inspired oxygen fraction in anaesthetized patients. Eur J Anaesthesiol 2005; 22: 420-425
123. Harten JM, Anderson KJ, Kinsella J, Higgins MJ. Normobaric hyperoxia reduces cardiac index in patients after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2005; 19: 173-175
124. Mak S, Azevedo ER, Liu PP, Newton GE. Effect of hyperoxia on left ventricular function and filling pressures in patients with and without congestive heart failure. Chest 2001; 120: 467-473
125. Farquhar H, Weatherall M, Wijesinghe M, et al. Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J 2009; 158: 371-377
126. Cason BA, Wisneski JA, Neese RA, et al. Effects of high arterial oxygen tension on function, blood flow distribution, and metabolism in ischemic myocardium. Circulation 1992; 85: 828-838
127. Meier J, Kemming G, Meisner F, Pape A, Habler O. Hyperoxic ventilation enables hemodilution beyond the critical myocardial hemoglobin concentration. Eur J Med Res 2005; 10: 462-468
128. Meier J, Kemming GI, Kisch-Wedel H, Blum J, Pape A, Habler OP. Hyperoxic ventilation reduces six-hour mortality after partial fluid resuscitation from hemorrhagic shock. Shock 2004; 22: 240-247